Clinical Trial Update: A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma [Phase 1]

View source ↗

Summary

This is a Phase 1 safety and dose-finding trial of GLIX1 in adults with recurrent or progressive high-grade glioma, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma

Drugs mentioned

• GLIX1

Snippet

Sponsor: Tetragon Biosciences Ltd | Conditions: Glioblastoma Multiforme of Brain, Glioma | Phase 1 | Status: NOT_YET_RECRUITING